>> MarketsThermo Fisher Beats Q2 Estimates and Lifts Full-Year Guidance, Shares Jump 5%
Thermo Fisher Scientific reported Q2 adjusted EPS of $6.03 against a $5.72 estimate and revenue of $11.99 billion, beating forecasts and prompting management to raise its full-year 2026 guidance. The result directly counters the sector anxiety that followed Danaher's weak outlook earlier this week.
[July 23, 2026]::READ -->
